Here, we investigate the DLK-dependent molecular and cellular network in hippocampal glutamatergic neurons, which show selective vulnerability in Alzheimer’s disease, ischemic stroke, and excitotoxic injury. This evidence concerns the gene DLK1 and early-onset autosomal dominant Alzheimer disease.